Asacol®
03010301A
Phase 3 small_molecule completed
Quick answer
Asacol® for Active Ulcerative Colitis is a Phase 3 program (small_molecule) at Tillotts Pharma AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tillotts Pharma AG
- Indication
- Active Ulcerative Colitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed